ARCHIVES

Susan Weiner Named to HHS Panel

This article is from The Cancer Letter archive.

Vol. 29 No. 03 | January 17, 2003

Download PDF Visit The Full Archive

Related Articles

Bad News for EPO Products Brings FDA Scrutiny, Payment Curbs. FDA Issues Alert to Doctors.

February 23, 2007

Program Announcement For Clinical Research

February 29, 1980

House Committee Investigates Marketing Practices Of Amgen And J&J For ESAs.

April 4, 2008

OCC to Take Over CIS Oct; Cost Sharing “Is Dead”

July 15, 1988

Study of Dlurectic Use As Renal Cell Cancer Risk Gets Concept Approval

March 10, 1989

Authorization Legislation Still On Congress Busy Agenda, Along With Risk Assessment, Appropriations

February 3, 1984